Phase I/II study of E7050 (golvantinib) in combination with sorafenib in patients (pts) with advanced hepatocellular carcinoma (HCC): Phase I results.
Bert H. O'Neil
No relevant relationships to disclose
Johanna C. Bendell
No relevant relationships to disclose
Manuel R. Modiano
No relevant relationships to disclose
Jean-Pascal H. Machiels
No relevant relationships to disclose
Melissa Jo Versola
No relevant relationships to disclose
Jeff Paul Hodge
No relevant relationships to disclose
Karen Sawarna
No relevant relationships to disclose
Nielson Tse
No relevant relationships to disclose